Patients with type 2 diabetes initiating exenatide twice daily or insulin in clinical practice: CHOICE study
2013
Introduction
Changes to Treatment and Outcomes in Patients with Type 2 Diabetes Initiating Injectable Therapy (CHOICE) is a European prospective, observational cohort study assessing time to, and factors associated with, a significant change in therapy after type 2 diabetes patients initiate their first injectable glucose-lowering therapy, and these patients’ clinical outcomes over 24 months. The authors report baseline data and factors associated with the injectable treatment regimen.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI